FDAnews Drug Daily Bulletin

CYLEX ANNOUNCES FIRST QUARTER 2006 REVENUES INCREASED 74 PERCENT OVER 2005

May 3, 2006
A A

Cylex Incorporated, a life sciences company and leader in immune function testing, today announced a 74 percent increase in first quarter revenues in 2006 to $603,000, up from 2005's first quarter revenues of $346,000. Clinical revenues alone increased 84 percent from 2005's first quarter. In fact, clinical sales have grown 48 percent in the current six months compared to the previous six months. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-02-2006/0004352479&EDATE=)